Title: Is DEB-TACE  as  locoregional  therapy  before  liver  transplantation  for  hepatocellular
  carcinoma effective?
Version: 3 Date: 16 Jul 2024
Reviewer's report:
1- Title:  It is better to be modified.
2- Abstract: It is better to write the full word before the abbreviation ( ??? AE , ??? MAV).
3- Introduction: Needs English editing.
4- Methods:
# It is better to perform flow chart for all of the patients during the study period and to illustrate
the inclusion and the exclusion criteria.
# It is better to add BCLC classification for all of the patients.
# The duration between chemoembolization and liver transplantation should be mentioned in
this section , not in the results section.
# The authors mentioned the baseline characters before the procedures , What about the
characters of the patients after the procedure ( any changes occurred as regard child score , portal
vein thrombosis , performance status).
# How can you consider Liver transplantation for those patients with progressive disease after
TACE?
5- Discussion:
# It is better to be modified.
# Limitations of the study : Retrospective , short term of follow up.
6- References:
More recent references better to be added.
Title: Is DEB-TACE  as  locoregional  therapy  before  liver  transplantation  for  hepatocellular
  carcinoma effective?
Version: 3 Date: 16 Jul 2024
Reviewer's report:
1- Title:  It is better to be modified.
2- Abstract: It is better to write the full word before the abbreviation ( ??? AE , ??? MAV).
3- Introduction: Needs English editing.
4- Methods:
# It is better to perform flow chart for all of the patients during the study period and to illustrate
the inclusion and the exclusion criteria.
# It is better to add BCLC classification for all of the patients.
# The duration between chemoembolization and liver transplantation should be mentioned in
this section , not in the results section.
# The authors mentioned the baseline characters before the procedures , What about the
characters of the patients after the procedure ( any changes occurred as regard child score , portal
vein thrombosis , performance status).
# How can you consider Liver transplantation for those patients with progressive disease after
TACE?
5- Discussion:
# It is better to be modified.
# Limitations of the study : Retrospective , short term of follow up.
6- References:
More recent references better to be added.
Please review this paper.
user
Title: Is DEB-TACE  as  locoregional  therapy  before  liver  transplantation  for  hepatocellular
  carcinoma effective?
Version: 3 Date: 16 Jul 2024
Reviewer's report:
1- Title:  It is better to be modified.
2- Abstract: It is better to write the full word before the abbreviation ( ??? AE , ??? MAV).
3- Introduction: Needs English editing.
4- Methods:
# It is better to perform flow chart for all of the patients during the study period and to illustrate
the inclusion and the exclusion criteria.
# It is better to add BCLC classification for all of the patients.
# The duration between chemoembolization and liver transplantation should be mentioned in
this section , not in the results section.
# The authors mentioned the baseline characters before the procedures , What about the
characters of the patients after the procedure ( any changes occurred as regard child score , portal
vein thrombosis , performance status).
# How can you consider Liver transplantation for those patients with progressive disease after
TACE?
5- Discussion:
# It is better to be modified.
# Limitations of the study : Retrospective , short term of follow up.
6- References:
More recent references better to be added.
assistant